These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3938412)

  • 1. Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease.
    Boss AH; Boysen G; Olseen JS
    Eur J Clin Invest; 1985 Dec; 15(6):412-4. PubMed ID: 3938412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease.
    Svensson J; Samuelsson K
    Thromb Res; 1983 Aug; 31(3):499-505. PubMed ID: 20218005
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of low dose acetylsalicylic acid upon plasma thromboxane B2 levels and platelet aggregation in ischemic stroke patients.
    Lee TK; Chen YC; Kuo TL; Lien IN; Liu MC; Huang ZS
    Clin Chim Acta; 1989 Oct; 184(3):323-8. PubMed ID: 2612002
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
    Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
    Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of inhibitory effects of low-dose ASA on thromboxane production and platelet aggregation in ischemic stroke patients.
    Lee TK; Ng SK; Huang ZS; Chen YC
    J Formos Med Assoc; 1992 Sep; 91(9):891-7. PubMed ID: 1363390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
    Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
    Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
    Nagatsuka K; Uyama O; Nakabayashi S; Yoneda S; Kimura K; Kamada T
    Stroke; 1985; 16(5):806-9. PubMed ID: 3931302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit.
    Lee TK; Chen YC; Lien IN; Liu MC; Huang ZS
    Stroke; 1988 May; 19(5):566-70. PubMed ID: 3363589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
    Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease.
    Boysen G; Boss AH; Odum N; Olsen JS
    Stroke; 1984; 15(2):241-3. PubMed ID: 6367153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses.
    Buerke M; Pittroff W; Meyer J; Darius H
    Am Heart J; 1995 Sep; 130(3 Pt 1):465-72. PubMed ID: 7661062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
    Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
    Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative antiplatelet effect of low-dose enteric coated aspirin.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Deykin D
    Br J Haematol; 1985 Aug; 60(4):635-42. PubMed ID: 3927970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-ranging study of the antiplatelet effect of enteric coated aspirin in man.
    Herd CM; Rodgers SE; Lloyd JV; Bochner F; Duncan EM; Tunbridge LJ
    Aust N Z J Med; 1987 Apr; 17(2):195-200. PubMed ID: 3476058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease.
    Matsumoto M; Kusunoki M; Uyama O; Fujisawa A; Matsuyama T; Yoneda S; Kimura K; Abe H
    Prostaglandins Med; 1981 Dec; 7(6):553-62. PubMed ID: 7323212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet function by low-dose plain and micro-encapsulated acetylsalicylic acid.
    Waldemar G; Petersen P; Boysen G; Knudsen JB
    Thromb Res; 1988 Apr; 50(2):265-72. PubMed ID: 3134739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects.
    Kallmann R; Nieuwenhuis HK; de Groot PG; van Gijn J; Sixma JJ
    Thromb Res; 1987 Feb; 45(4):355-61. PubMed ID: 3576521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.
    Dabaghi SF; Kamat SG; Payne J; Marks GF; Roberts R; Schafer AI; Kleiman NS
    Am J Cardiol; 1994 Oct; 74(7):720-3. PubMed ID: 7942533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.